The UCSF-GIVI CFAR Specimen Bank Core has since 1987 provided expertise and an infrastructure for the collection, processing and storage of biospecimens for CFAR investigators. The Specimen Bank Core, under the director of Dr. John S. Greenspan and Ms. Yvonne De Souza has provided repository services to many cohorts and clinical studies based in San Francisco, including the Women's Interagency HIV Study (WINS), Options Project (Primary HIV infection), Staying Well (Clinical trial of mindfulness-based stress reduction and education groups for HIV), SFGH Observational Cohort Evaluating Long-Term Consequences of Virologic Failure (SCOPE), and a recently funded NIH study, Men of Asia testing for HIV (MATH). The Specimen Bank Core has received over 295,000 deposits and has shipped over 275,000 specimens aliquots worldwide, including whole blood, serum, plasma, leukocytes, fresh frozen and fixed tissue, urine, saliva (stimulated and unstimulated), semen, cerebrospinal fluid, oral and vaginal mucosal swabs, and cervico-vaginal lavage. A goal of the Core is to continue its current repository functions and to further develop as a local and national source for investigators pursing translational research.
Specific Aims of the Specimen Bank Core (SBC) are to: 1. Process, inventory, and store (short and long term) biospecimens collected from CFAR investigators. 2. Provide well-characterized biospecimens to support CFAR investigations and to provide specimens to non-CFAR investigators to enhance collaboration between CFAR and non-CFAR investigators. 3. Provide consultation and training for CFAR investigators seeking information on optimal specimen collection, processing, storage, and shipment. 4. Advise the International Core in specimen banking and storage procedures.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Center Core Grants (P30)
Project #
5P30AI027763-20
Application #
8331625
Study Section
Special Emphasis Panel (ZAI1)
Project Start
Project End
Budget Start
2011-09-01
Budget End
2012-08-31
Support Year
20
Fiscal Year
2011
Total Cost
$217,825
Indirect Cost
Name
University of California San Francisco
Department
Type
DUNS #
094878337
City
San Francisco
State
CA
Country
United States
Zip Code
94143
Pulugulla, Sree H; Packard, Thomas A; Galloway, Nicole L K et al. (2018) Distinct mechanisms regulate IL1B gene transcription in lymphoid CD4 T cells and monocytes. Cytokine 111:373-381
Mohamed, Tamer M A; Ang, Yen-Sin; Radzinsky, Ethan et al. (2018) Regulation of Cell Cycle to Stimulate Adult Cardiomyocyte Proliferation and Cardiac Regeneration. Cell 173:104-116.e12
Chammartin, Frédérique; Zürcher, Kathrin; Keiser, Olivia et al. (2018) Outcomes of Patients Lost to Follow-up in African Antiretroviral Therapy Programs: Individual Patient Data Meta-analysis. Clin Infect Dis 67:1643-1652
Vardi, Noam; Chaturvedi, Sonali; Weinberger, Leor S (2018) Feedback-mediated signal conversion promotes viral fitness. Proc Natl Acad Sci U S A 115:E8803-E8810
Carrico, Adam W; Flentje, Annesa; Kober, Kord et al. (2018) Recent stimulant use and leukocyte gene expression in methamphetamine users with treated HIV infection. Brain Behav Immun 71:108-115
Bengtson, Angela M; Pence, Brian W; Eaton, Ellen F et al. (2018) Patterns of efavirenz use as first-line antiretroviral therapy in the United States: 1999-2015. Antivir Ther 23:363-372
Sauceda, John A; Lisha, Nadra E; Neilands, Torsten B et al. (2018) Cognitive-affective depressive symptoms and substance use among Latino and non-Latino White patients in HIV care: an analysis of the CFAR network of integrated clinical systems cohort. J Behav Med :
Carrico, Adam W; Cherenack, Emily M; Roach, Margaret E et al. (2018) Substance-associated elevations in monocyte activation among methamphetamine users with treated HIV infection. AIDS 32:767-771
Tymejczyk, Olga; Brazier, Ellen; Yiannoutsos, Constantin et al. (2018) HIV treatment eligibility expansion and timely antiretroviral treatment initiation following enrollment in HIV care: A metaregression analysis of programmatic data from 22 countries. PLoS Med 15:e1002534
Martin, Maureen P; Naranbhai, Vivek; Shea, Patrick R et al. (2018) Killer cell immunoglobulin-like receptor 3DL1 variation modifies HLA-B*57 protection against HIV-1. J Clin Invest 128:1903-1912

Showing the most recent 10 out of 1541 publications